Institutional investors purchased a net $4.6 million shares of VSTM during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 46.72% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EMERALD ADVISERS, INC. Bought 552.2 Thousand shares of Verastem Inc
FIRST EAGLE INVESTMENT MANAGEMEN... Bought 492.7 Thousand shares of Verastem Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 436.9 Thousand shares of Verastem Inc